• June 19, 2024

Clinical diagnostics – Research and development

Several years of research are based on the immunochemistry of small size molecules (< 1000 Daltons) including aminoacids, neurotransmitters, neuromodulators, sugar, vitamins, lipids, hormones, fatty acids…

In the meantime, a new concept appeared following relevant experimental observations: direct participation of small molecules in some pathogenic processes.

Focus: Identification of specific antibodies to small size molecules (new markers) circulating in patients affected by chronic degenerative or autoimmune diseases:

Multiple Sclerosis (MS)

Amyotrophic Lateral Sclerosis (ALS)

Rheumatoid arthritis (RA)

Parkinson disease

Alzheimer disease

Atypical neuropathies